-
Halazone and Sodium Current Inactivation in Frog Fibers
2026-08-24
A 1986 voltage-clamp study used Halazone and several chemically selective reagents to test whether methionine, sulfhydryl, histidine, tyrosine, or arginine residues control sodium-current inactivation in frog myelinated nerve fibers. Halazone and hypochlorous acid strongly disrupted inactivation, while the comparative reagent pattern argued against a uniquely methionine-centered mechanism and supported a tentative role for chemically modifiable membrane components, including lipids.
-
AZD3463: ALK/IGF1R Inhibitor Research Guide
2026-08-24
AZD3463 is an orally bioavailable ALK/IGF1R inhibitor for preclinical ALK-driven cancer research. The product dossier describes activity against wild-type and mutant ALK, PI3K/AKT/mTOR pathway suppression, enhanced chemotherapy response, and tumor-growth reduction in orthotopic neuroblastoma xenografts.
-
Captopril Beyond ACE: A Translational Research Playbook
2026-08-23
Captopril is more than a benchmark ACE inhibitor for hypertension research. By connecting ACE inhibition with bradykinin B2 receptor biology, this article outlines a translational workflow for studying vascular, gastrointestinal, and preclinical cancer phenotypes while distinguishing established evidence from testable hypotheses.
-
Stiripentol, LDH, and Lactate Flux in Epilepsy
2026-08-22
Explore how Stiripentol, a noncompetitive LDH inhibitor, can be used to interrogate lactate flux, astrocyte-neuron lactate shuttle modulation, and seizure biology. This article translates recent histone lactylation findings into practical assay decisions while distinguishing established evidence from testable research hypotheses.
-
NIID Patient iPSC Model with NOTCH2NLC Expansion
2026-08-21
This resource study establishes HZSMHCi002-A, a patient-derived induced pluripotent stem cell line carrying a GGC repeat expansion in the 5′ untranslated region of NOTCH2NLC, a major genetic cause of neuronal intranuclear inclusion disease. The line provides a characterized starting point for modeling NIID cellular pathology and testing future interventions, while its single-donor design and lack of gene correction define important limits for interpretation.
-
Nintedanib: ATRX-Stratified Research Design
2026-08-20
Nintedanib (BIBF 1120) is a triple angiokinase inhibitor suited to mechanism-driven angiogenesis and tumor studies. This article develops an ATRX-stratified assay framework that connects receptor tyrosine kinase biology with practical decisions about controls, endpoints, exposure, and translational limits.
-
SGI-1027: A DNMT Inhibitor for Smarter Cancer Assays
2026-08-20
SGI-1027 is a DNA methyltransferase inhibitor that connects DNMT biochemistry with more rigorous cancer-cell response assays. This guide explains how to distinguish growth inhibition from cell killing when evaluating DNA methylation inhibition and tumor suppressor gene reactivation.
-
Sisomicin Workflows for Antibacterial Research
2026-08-19
Build more informative Sisomicin studies by pairing broth susceptibility with time-kill, intracellular, and exposure–response designs. This workflow helps distinguish direct antibacterial activity from cell penetration, inoculum, resistance, and pharmacokinetic effects across Gram-negative and Gram-positive models.
-
RG7388: Reliable MDM2 Antagonist Assays
2026-08-19
Learn how RG7388 (MDM2 antagonist, oral, selective), SKU A3763, can improve the design and interpretation of biochemical, viability, proliferation, and apoptosis assays. This scenario-based guide connects p53 biology with practical solvent, dosing, control, and vendor-selection decisions.
-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-08-18
The reference study used voltage-clamped frog nerve fibers to compare Halazone and related chemical reagents as probes of sodium-current inactivation. Its contrasting reagent responses weakened the case for a uniquely essential methionine residue and instead supported a cautious membrane-lipid explanation, while also defining important limits for translating neurophysiological findings to water disinfection or antimicrobial resistance research.
-
EZ Cap™ Cy5 EGFP mRNA: A Two-Clock Assay
2026-08-18
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates cellular uptake from productive translation through Cy5 and EGFP signals. This article presents a morphology-aware framework for interpreting mRNA delivery data and designing more decisive gene regulation studies.
-
Nintedanib: An ATRX-Aware Research Framework
2026-08-17
Nintedanib (BIBF 1120) offers a powerful way to study coordinated VEGFR, FGFR, and PDGFR signaling. This article presents an ATRX-aware assay framework that separates direct tumor-cell vulnerability from vascular and stromal effects.
-
β-Elemene Inhibits Adipogenesis via AMPK
2026-08-17
The reference study identifies β-Elemene as an inhibitor of MDI-induced adipogenesis in 3T3-L1 cells and connects this effect with restoration of AMPK-pathway activity. Its in vitro design provides a useful framework for examining lipid accumulation, insulin resistance, glucose handling, and signaling responses, while leaving in vivo efficacy and molecular target validation for future work.
-
Anti Reverse Cap Analog for Synthetic mRNA
2026-08-16
Learn how orientation-specific 5′ capping can improve synthetic mRNA translation, from in vitro transcription setup to cell-reprogramming workflows. Practical parameters, assay choices, and troubleshooting guidance connect ARCA chemistry with transgene-free oligodendrocyte differentiation research.
-
AI-10-49 Workflow for CBFβ-SMMHC Inhibition
2026-08-15
AI-10-49 connects direct CBFβ-SMMHC–RUNX1 dissociation with chromatin, transcriptional, viability, and animal-model readouts. This mechanism-led workflow helps distinguish selective target engagement from nonspecific leukemia cell toxicity in acute myeloid leukemia research.